5-aza treatment of breast cancer and non-tumorigenic breast cells
CpG hypermethylation in gene promoters is a frequent mechanism of tumor suppressor gene silencing in various types of cancers. 5-aza-2'-deoxycytidine (AZA) is a DNA demethylating and anti-cancer agent resulting in induction of genes suppressed via DNA hypermethylation.
Cancer Type: Breast Cancer
GPL: 570
Number of Genes with Data: 978
Number Observations: 18
Number Outputs: 2
Imbalanced Ratio: 1
Default Task: Classification